
Baofa Yu, M.D. Kaitohutohu Tumuaki i Haina, Ahorangi Tohunga i te Whare Wananga o Texas (El Paso) (2016) me te Ahorangi Tuarua i te Whare Wananga o te Hauauru o te Hauora (2016). I puta ia mai i te Peking Union Medical College (Peking Union Medical College) i te tau 1988. Ko ia he hoa pou-taakuta i UCSD mai i te 1990 ki te 1991, ko Salk mai i te 1992 ki te 1993, te Kaiawhina Kaiawhina Ahorangi, UCSD mai i te 1994 ki te 1998. I hangaia e ia te ariā hou mo te whakamahi i te kiko pukupuku hei punaha tuku pumau o nga raau taero anticancer me te tikanga maimoatanga o te puna tuku toiwhi, he uara tono haumanu, ka kiia hoki ko te ultro-Minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC). I te 1998, ka hoki ia ki Haina me te whakatu i te Whare Rangahau a Shandong Baofa me te Taimei Baofa Cancer Hospital i te taiwhenua o Dongping me te haumi hangarau, a ka noho hei tiamana mo Shandong Baofa Cancer Treatment Co., LTD., a, i muri mai ka whakatuhia a Jinan Baofa Cancer Hospital (2004). Dongping Baofa General Hospital (2011), Beijing Baofa Cancer Hospital (2013) me Immuno Oncology Systems, Inc. He haumaru tenei UMIPIC, he ngawari ki te whakahaere, ka taea te whakaputa me te painga pai mo nga pukupuku totoka katoa. I tenei ra ka whakaaetia tenei rongoa ki te "Aratatohu Mahi Haumanu mo te Whakawhanaketanga o te Mate Pancreatic Ake" (Trial) (7th edition), i hangaia tahi e te Hainamana Anti-Cancer Association, te National Clinical Medical Research Center mo te Radiology and Therapy, me te National Interventional Medicine Innovation Alliance, Journal of Clinical Radiology, pukapuka 43, nama 149, 163.
Neke atu i te 60 nga pepa kua whakaputaina e ia mo tenei rongoa i roto i te Nature:Scientific Report, Journal of Cancer, J Basic Clin Pharma, J Immunological Sci, Japanese Journal of Gastroenterology and Hepatology, Novel Approaches in Cancer Study, Academic Journal of Engineering Studies, Nov Res Sci, Journal of Hepatocellular carcinoma, lung Cancer: Target and Therapy, Journals of Live Research Chest,Proc.Natl.Acad.Sci.USA, Pancreas me etahi atu hautaka me te maha o nga pepa panui i uru ki te hui AACR me ASCO.
Ko ta matou koha nui ko te whakamaarama tuku toimau e whakauru ana i nga painga o te chemotherapy me te immunotherapy, a, mo te wa tuatahi, kua honoa nga mea e rua me te tono ki te rongoa intratumoral na roto i te wawaotanga. Ka whakauruhia te maimoatanga o te rohe me te ao, me te whakanui ake i te kukū me te wa o te mahi tarukino na roto i te tuku tonu o nga raau taero i roto i te puku, ehara i te mea e whai hua ana te mate pukupuku o te rohe o nga rongoa chemotherapy, engari ka whai whakaaro ano hoki ki te mahi o te immunotherapy punaha, na reira ka whakatika i nga ngoikoretanga o etahi atu rongoa, e whakarato ana i nga whakaaro hou me nga huarahi mo te maimoatanga mate pukupuku, ina koa mo nga pukupuku o waenga me te mate pukupuku, ina koa mo te whakaheke i te nui o te mate pukupuku; Ko te rongoa UMPIC he painga ki te whakamahi i te puku hei puna antigen me te kano kano autologous, e rite ana ano ki te ahua whanaketanga o te rongoa Whaiaro. Na ka tono ki te whare haumanu, hapten me nga raau taero chemotherapy mo te rongoa tuku tonu o te mate pukupuku pancreatic arotahi tuatahi, i te wa e whakaohooho ana i te awenga tawhiti, ko te tino kaupapa ko te kii i te urupare aukati, CD4, CD8, DC, T me te NK nga pūtau, me nga autoantibodies puku e pa ana ki te pūtau-B: Antibodies ki P53, P16, Cvivides. p62, HCC1 me etahi atu oncogenes, koinei te wa tuatahi ki te kite kei te uru a T me B ki roto i te urupare aukati, a ko nga mahi haumanu o te paanga tawhiti me tenei rongoa i tohua mo te "Aratatohu Mahi Haumanu mo te Whakamaahia o te Mate Pancreatic Advanced" (Trial) (7th edition) i hangaia tahitia e te Chinese Anti-Cancerrap Association, te National Clinical and Medical The Association, te National Clinical and Medical The Alliance. i whakaputaina i Journal of Clinical Radiology, pukapuka 43, nama 19, 2024, 1636-1648.
| Tau | Taitara Tuhinga | Whakaputa |
| 2015 | Te whakakaha ake i nga mahi rongoa i roto i nga waahanga o mua o te mate pukupuku pūkahukahu na roto i te werohanga ultra-iti rawa ki te intratumoral whaiaro | Te Matepukupuku Pukahukahu: Te Whainga me te Whakaora, 2015;6 1-11 |
| 2015 | Te tiaki i te mea noa kia pai ake te patu i te mate pukupuku | 2015 Ko nga Kaituhi. Te rongoa mate pukupuku i whakaputaina e John Wiley & Sons Ltd.1349-1403 |
| 2015 | Nga ngoikoretanga me nga raru o te whakamahi i nga kiore me nga kiore i roto i nga rangahau mo te mate pukupuku | Journal of Cancer 2015;6(10): 1058-1065.doi: 10.7150/jca.12519 |
| 2015 | Whakanuia ake te wa ora katoa i roto i te mate pukupuku hepatocellular matatau na roto i te werohanga ultra-iti mo te chemoimmunotherapy intratumoral whaiaro | Journal of Hepatocellular Carcinoma, 2015:2,1-12 |
| 2015 | Te whakamahi i nga raau taero Catatonic whakakotahi hapten mo te Whakapai ake i te Paanga Hauora i nga waahanga Ake o te mate pukupuku Pancreatic | Journal of Liver Research, Disorders & Therapy, 2015,1(3):013-23 |
| 2016 | Te Ako mo te Hiranga o te Whakakore i te Huringa mai i nga mate pukupuku ka taea te rongoa me nga pukupuku pai | Journal of Cancer 2016; 7(4): 436-445. doi: 10.7150/jca.13832 |
| 2016 | Hapten I whakapai ake i te katoa o nga painga mo te oranga i roto i nga wahanga o muri o te mate pukupuku pūtau iti-kore (NSCLC) na te Ultra-Minimum Incision Personalized Intratumoral Chemo Immunotherapy (UMIPIC) Therapy With and without Radiation Therapy Tukua Manuscript | Journal of Cancer Prevention & Current Research 2016, 4(2): 00116 |
| 2020 | He huarahi hou mo te rongoa mate pukupuku me te maripi wai me te rongoa mate mate: UMIPIC, tera pea ka eke ki te maha o nga pokanga, haumanu me te whakamaarama iraruke mo nga wahanga katoa o te puku totoka. | Nga Tikanga Hou mo te Akoranga Matepukupuku NACS.000590. 4(3).2020 |
| 2020 | Whakaranuhia te rongoa ma te weronga H2O2 Intratumoral ki te huri i tetahi Matrix Extracellular ki roto i te Coagulum Autologous hei Putunga Taauau | Rangahau hou i roto i te Pūtaiao NRS.000584. 4(2).2020 |
| 2020 | He tumanako hou mo te rongoa mate pukupuku me te maripi wai me te rongoa mate mate: UMIPIC | Nga Tikanga o naianei i roto i nga Putaiao Haumanu me te Hauora ISSN:2689-4246 Te Ra Whakaputa: Maehe 20, 2020 |
| 2022 | Te Mua Tumor Acute ki te CD4/8+ me te CD11+ Whakarei ake i te Wā Ora Roa i roto i nga Taumata Ake o nga pukupuku totoka katoa na te Ultra Minimum Incision Whaiaro Intratumoral Chemoimmunotehrapy | Hapanihi Journal of Gastroenterology and Hepatology |
| 2022 | He Mua Nui me te Whakaaturanga Motuhake o te CD11 me te CD4 Ka Whakaputa i te Painga Abscopal na roto i te Intramoral Injection Chemotherapy Drug me te Hapten i roto i te Tauira Kararehe | Journal of Immunological Sciences |
| 2022 | He Waa Hou o te Haapara Whakamatea Kei te Haere Mai : He Tikanga Awhina Hou mo te maimoatanga mate pukupuku me te Naipi Wai me te Hauora Mate. | Academic Journal of Engineering Studies |
| 2022 | Te Mua Tumor Acute ki te CD4/8+ me te CD11+ Whakaroa i te Paanga Ora I ahu mai e te Intratumral Injection Ko te Whakakotahitanga Pai rawa atu o nga raau taero Chemotherapy me te Hydralazine hei Hapten i roto i te tauira kararehe. | Hapanihi Journal of Gastroenterology and Hepatology |
| 2023 | Whakaarahia nga Pūtau Whakatairanga na te Hapten Enhanced Intratumoral Chemotherapy me te Penicillin Kia roa te ora o te mate pukupuku pancreatic. | Journal of Cancer 2023; 14(8): 1282-1292 |
| 2023 | Ko te whainga angitu i roto i te waahi o tetahi antigen karihi oncogenic na te hapten induced tumor associated autoantibodies (iTAA) | nature portfolios Purongo Putaiao pukapuka 13, Tuhinga: 9902 (2023) |
| 2023 | Ko nga Huringa Kaahui na te Intratumoral Hapten Plus Chemotherapy Drugs o te EndometrialCancer | Journal of Basic and Clinical Pharmacy Hōngongoi 31,2023. DOI: 10.37532/0976-0113.14(S1).17 |
| 2023 | Matepukupuku Te Whakaritenga Whakatairanga Whakaora me te Whakahohenga o nga Waa-a-Tara i roto i te Hapten-Enhanced Chemotherapy i roto i te Matepukupuku Pukahukahu Tuatahi | Journal of Basic and Clinical Pharmacy August 11, 2023. DOI: 10.37532/0976-0113.14(S1).18 |
| 2023 | scRNA-Seq Analysis Nga Huringa Whakarerenga o Intratumoral Hapten Plus Chemotherapy Drugs mo te maimoatanga o te mate pukupuku uma tane | JOURNAL OF CANCER SCIENCE AND CINICAL THERAPEUTICS November 27, 2023. DOI:10.26502/jcsct.5079214 |
| 2024 | Te painga o te konutai stibogluconate i roto i te kimi me te whakaoho i nga pūtau parepare i roto i te wai pleural o te whakarite mate pukupuku pancreatic mo te immunotherapy | Frontiers in Immunology Hanuere 19, 2024. DOI:10.3389/fimmu.2023.1315468 |
| 2024 | Hapten-Mediated Chemical Immune Therapy with Drug Administration into Cervical Cancer without Hysterectomy | Journal of Surgery June 13, 2024. DOI:10.29011/2575-9760.11063 |
| 2024 | Whakamahia te scRNA-Seq Profile ki te Tautu i te Whakautu Immunologic i muri i te Intra-tumor Hapen Enhanced Chemotherapy i runga i tetahi keehi o Intracranial Anaplastic Hemangiopericytoma ate Metastasis: He Ripoata Take | Journal of Surgery Pipiri 10, 2024. DOI:10.29011/2575-9760.11063 |